Cart  |  Log In


Gene Expression & Reporter Assays - Product Profiles

The Dual-Glo™ Luciferase Assay System

The Dual-Glo™ Luciferase Assay System(a,b,c,d) provides high z-factors and reliable results for cell-based highthroughput screening applications. The system enables the fastest and simplest, independent measurement of stable luminescence from two reporter genes in a single sample. In the Dual-Glo™ Luciferase Assay, the activity of your primary reporter is correlated with the effect of specific stimuli and the activity of the co-transfected control reporter provides an internal control to normalize results. Not only do you get reduced sample variability (one of the primary sources of error in cell based screening), you now have a simple, robust and elegant solution for discriminating between specific down regulation and cytotoxicity in the same assay!

Advantages of The Dual-Glo™ Luciferase Assay System

     

Increased Precision and Accuracy:
Normalize your primary reporter results with an internal control. Co-reporter minimizes effects of cell number, cell health, transfection efficiency and non-specific cellular responses.

Homogeneous Format:
Perform fewer steps. Cells may be assayed directly in growth medium for both reporters. No centrifugation required.

Stable Signal:
Obtain flexibility for either batch or continuous processing of 96, 384 & 1536 well plates. Each luminescent signal may be measured for up to 2 hours after reagent addition.

 

Convenience:
Screen efficiently with this simple, two-step assay that is ideal for your luminometer. Injectors not required.

Wide Range:
Analyze high and low reporter activity without sample dilution. Linear over at least 6 logs of enzyme concentration for each reporter.

     

With the Dual-Glo™ Assay, you have a powerful and reliable method to deconvolute your data by enabling you to discriminate between specific and non-specific cellular responses. Single reporter, uncorrected data cannot distinguish between specific down regulation and cytotoxicity, as both responses exhibit a similar decrease in luminescence. In the Dual-Glo ™ Assay, however, the use of dual reporters can discriminate these responses through normalization.

     
     

Figure 1. Single Reporter, uncorrected data cannot distinguish specific down regulation from a cytotoxic response: Transiently transfected CHO cells expressing Renilla luciferase under control of the Tet-Off promoter and firefly luciferase under the control of the CMV promoter (luc+ in pCI plasmid from Promega) were exposed to varying concentrations of either Doxycycline (a specific inhibitor that down regulates expression of the Tet-Off promoter) or G418 (a general inhibitor which is cytotoxic to cells). All data was generated using the Dual-Glo™ Luciferase Assay System.

Panel A: Luminescence from the uncorrected experimental reporter, Renilla luciferase, is shown compared to the concentration of the inhibitor Doxycylcine.

Panel B: Luminescence from the uncorrected experimental reporter, Renilla luciferase, is shown compared to the concentration of the general inhibitor G418. The data illustrates that single reporter results cannot distinguish between cytotoxicity and specific down regulation. Non-normalized Reporter CV= 22%.

     
     

Figure 2. Dual Reporter, corrected data can isolate specific down regulation from a cytotoxic response: Renilla Luciferase luminescence is normalized to the luminescence of the co-expressed firefly luciferase. This relative effect is then correlated to the maximal response to generate a Relative Response Ratio (RRR= [ratio of normalized experimental sample - ratio of untreated sample]/[ratio at the maximum effect (200 µg/ml doxycycline) - ratio of untreated sample].

Panel C: The Relative Response Ratio is shown compared to the concentration of the specific inhibitor, Doxycycline.

Panel D: The Relative Response Ratio is shown for the general inhbitor, G418. The data demonstrates that by normalizing the Renilla luciferase expression to the firefly luciferase expression to generate a Relative Response Ratio results in the differentiation of a specific response from a non-specific response. Relative Response Ratio CV = 13%. For all data points, n=12 wells in a 96-well plate, integration time=0.5 seconds per well. Tet-Off plasmids pUHD15-1 and pUHD10-3 provided by B Callus (Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115).

     
     

Technical Resources for all Luminescence products

     

(a) Products may be covered by issued or pending patents.
(b) U.S. Pat. No. 5,744,320, Australian Pat. No. 721172 and other patents pending.
(c ) U.S. Pat. Nos. 5,283,179, 5,641,641, 5,650,289, 5,814,471, Australian Pat. No. 649289 and other patents pending.
(d) Certain applications of this product may require licenses from others.

Dual-Glo, Bright-Glo and DLReady are trademarks of Promega Corp. Dual-Luciferase, Steady-Glo and Stop & Glo are trademarks of Promega Corporation and are registered with the U.S. Patent and Trademark Office.